The latest publication by the PROOF Centre indicates that proteo-genomic biomarker ensemble classifiers show promise in the diagnosis of acute rejection in kidney transplant recipients, and can improve classification performance beyond that of individual genomic or proteomic classifiers alone. Click here to learn more about the PROOF Centre’s work on creating effective proteo-genomic panels to improve acute rejection classification performance.

A More Promising Way to Diagnose Acute Rejection in Kidney Transplant Recipients